Trevena

Trevena Announces Two OLINVYK Abstracts Highlighting Safety Data Accepted at ANESTHESIOLOGY 2021

CHESTERBROOK, PA — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, this week announced …

Trevena Announces Two OLINVYK Abstracts Highlighting Safety Data Accepted at ANESTHESIOLOGY 2021 Read More